CI:NYE-Cigna Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 280.06

Change

-1.57 (-0.56)%

Market Cap

N/A

Volume

0.67M

Analyst Target

USD 242.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

-0.24 (-0.05%)

USD 460.26B
ELV Elevance Health Inc

+2.05 (+0.55%)

USD 88.46B
CNC Centene Corp

+0.58 (+0.96%)

USD 30.08B
MOH Molina Healthcare Inc

+0.69 (+0.23%)

USD 16.86B
OSCR Oscar Health Inc

-0.20 (-1.47%)

USD 4.09B
NEUE NeueHealth Inc

+3.23 (+74.94%)

USD 0.05B
CVS CVS Health Corp

+0.11 (+0.25%)

N/A
HUM Humana Inc

-0.22 (-0.09%)

N/A

ETFs Containing CI

FHI:CA CI Health Care Giants Cov.. 4.97 % 0.75 %

-0.01 (0.00%)

CAD 0.08B
AILV 4.45 % 0.00 %

N/A

N/A
PINK Simplify Exchange Traded .. 3.86 % 0.00 %

+0.11 (+0.00%)

USD 0.15B
CBUF:F iShares V Public Limited .. 3.27 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.22 % 0.00 %

N/A

N/A
FSST Fidelity Sustainability U.. 2.36 % 0.00 %

+0.25 (+0.00%)

USD 0.02B
IQSA:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IQSE:F Invesco Quantitative Stra.. 1.53 % 0.00 %

N/A

N/A
DMFC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

N/A
IS07:XETRA iShares Edge MSCI World M.. 1.30 % 0.00 %

N/A

USD 0.01B
IBCZ:XETRA iShares Edge MSCI World M.. 1.11 % 0.00 %

N/A

USD 0.40B
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.08 (+0.00%)

USD 0.05B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.07 (+0.00%)

N/A
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.19 (+0.00%)

N/A
RYH 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.31 (+0.00%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

+0.87 (+0.00%)

N/A
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.64 (+0.00%)

USD 9.69M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.65 (+0.00%)

USD 0.26B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+3.02 (+0.00%)

USD 0.22B
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.40B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.01 (+0.00%)

CAD 0.09B
NTZG 0.00 % 0.00 %

N/A

N/A
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.48% 75% C 22% F
Dividend Return 1.87% 80% B- 31% F
Total Return -4.61% 75% C 20% F
Trailing 12 Months  
Capital Gain -6.68% 75% C 22% F
Dividend Return 1.87% 80% B- 32% F
Total Return -4.82% 75% C 20% F
Trailing 5 Years  
Capital Gain 37.03% 67% D+ 69% C-
Dividend Return 9.32% 50% F 28% F
Total Return 46.35% 67% D+ 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 14.11% 75% C 73% C
Dividend Return 15.64% 75% C 72% C
Total Return 1.53% 80% B- 37% F
Risk Return Profile  
Volatility (Standard Deviation) 22.69% 75% C 48% F
Risk Adjusted Return 68.92% 88% B+ 81% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:

There is nothing we particularly dislike